P-32 and I-125 Radiation Safety in the Lab

P-32 and I-125 are two of the most common radionuclides in biomedical research, and they demand almost opposite radiation safety controls. P-32 is a high-energy pure beta emitter that you shield with low-atomic-number acrylic — never lead — and monitor for skin and extremity dose. I-125 is a low-energy photon emitter that a sliver of lead stops cold, but that concentrates in the thyroid if it gets inside you, so it is managed with thyroid bioassay. Getting the control to match the physics is the entire discipline.

Walk into almost any molecular biology or radioimmunoassay lab and you will find these two isotopes. P-32 labels nucleotides and phosphorylation substrates; I-125 labels antibodies, hormones, and peptides. Both are byproduct material regulated by the Nuclear Regulatory Commission or an Agreement State, both are used unsealed, and both are easy to use safely — if the program understands what makes each one hazardous. The failure mode is treating them the same. A worker who shields P-32 behind the lead brick that works for a gamma source is actively making things worse, and a worker who focuses on external I-125 dose while ignoring thyroid intake is watching the wrong hazard. This article lays out the physics of each isotope and the radiation safety program that follows from it. DRPS provides this support as part of its radiation safety officer and radioactive material license support services.

Introduction

Radiation safety for unsealed radionuclides rests on a short list of questions: what does the isotope emit, how penetrating is it, what shields it, what happens if it gets inside the body, and how do you detect a problem. For sealed gamma sources those answers are familiar. For the beta and low-energy-photon emitters of the research bench, the answers are different enough that habits imported from the imaging suite can mislead.

P-32 and I-125 are the clearest illustration of why. They sit at opposite ends of the research-radionuclide hazard spectrum: a hard beta emitter whose external dose is all about skin and hands and whose shielding is a counterintuitive "low-Z, not lead," and a soft photon emitter whose external dose is trivial to shield but whose internal thyroid hazard drives a bioassay program. Understanding both teaches the general method. For the low-energy beta companions to this story — tritium and carbon-14 — see our article on C-14 and tritium radiation safety, and for the general shielding principle, beta and bremsstrahlung shielding.

Topic Explanation

P-32: a high-energy pure beta emitter

Phosphorus-32 decays by beta-minus emission with a half-life of about 14.3 days, converting to stable sulfur-32. It is a pure beta emitter — there is no accompanying gamma ray — and its beta spectrum is hard, with a maximum energy (endpoint) of 1.71 MeV and an average energy of roughly 0.69 MeV.¹ Those energetic betas travel several millimeters in tissue, which makes P-32 primarily an external skin-and-extremity hazard at the bench and a concern for the eyes of a worker leaning over an unshielded source.

Two features define P-32 safety. First, the betas are penetrating enough to deliver meaningful skin and finger dose but short-ranged enough to be stopped entirely by a modest thickness of material. Second — and this is the counterintuitive part — the choice of shielding material matters as much as the thickness, because stopping fast electrons generates bremsstrahlung x-rays, and the amount depends strongly on the atomic number of the stopping material.

I-125: a low-energy photon emitter and a thyroid seeker

Iodine-125 decays by electron capture with a half-life of about 59.4 days. Electron capture leaves the daughter tellurium-125 atom with an inner-shell vacancy that fills with a cascade of characteristic x-rays, and the decay also produces a 35.5 keV gamma ray (emitted in about 7% of decays).¹ The net external radiation is a band of low-energy photons between roughly 27 and 35 keV.

Those soft photons make external shielding almost trivial: unlike a 364 keV I-131 gamma, a 27 to 35 keV photon is stopped by a fraction of a millimeter of lead. But I-125 is iodine, and iodine goes to the thyroid. If unsealed I-125 — especially in a volatile chemical form — is inhaled or ingested, it concentrates in the thyroid gland, where it delivers a committed dose. The governing hazard for I-125 is therefore internal, and the program is built around containment and thyroid bioassay rather than external shielding.

Key Technical Principles

Shielding P-32: range sets the thickness

The thickness of shielding needed for a beta emitter is set by the beta range. Expressed as an areal density, the continuous-slowing-down (CSDA) range of a 1.71 MeV electron in water is approximately 0.79 g/cm². Converting to a physical thickness in a material of density $\rho$:

For acrylic (polymethyl methacrylate, $\rho =1.18g/c{\mathrm{m}}^3$):

and in tissue or water ($\rho \approx 1.0g/c{\mathrm{m}}^3$) the range is about 0.79 cm, or roughly 8 mm. Because the CSDA range describes the average path and underestimates the most penetrating betas (it ignores straggling), standard practice rounds up: about 10 mm (three-eighths inch) of acrylic stops essentially all P-32 betas with margin.

Shielding P-32: why not lead

Here is the key principle. When a fast electron is stopped, part of its energy is radiated as bremsstrahlung — penetrating x-rays. The fraction radiated scales with the atomic number $Z$ of the stopping material. A widely used approximation for the radiation yield is:

For lead ($Z=82$): $f\approx 3.5\times 10^{-4}(82)(1.71)\approx 0.049$, about 4.9% of the beta energy radiated as bremsstrahlung. For acrylic (effective $Z\approx 6.5$): $f\approx 3.5\times 10^{-4}(6.5)(1.71)\approx 0.0039$, about 0.4%. The approximation is a teaching figure, not a dosimetric prediction — the authoritative radiation-yield value for low-Z media from stopping-power data is on the order of 1% at this energy — but the direction is firm and confirmed by Monte Carlo and measured studies: a high-Z material produces roughly an order of magnitude more bremsstrahlung than a low-Z material for the same beta source.^{2, 9, 10, 11}

That is why the primary P-32 shield is acrylic, not lead. A lead brick placed against a P-32 source stops the betas but converts a larger share of their energy into penetrating x-rays that then escape — you have traded a short-range beta hazard for a longer-range photon hazard. At the microcurie-to-millicurie activities of a typical research bench, a centimeter of acrylic produces negligible bremsstrahlung and is the correct and sufficient shield. Only at very high activities does bremsstrahlung become a design concern, and then the solution is a thick low-Z primary shield, sometimes backed by a thin high-Z layer to absorb the residual x-rays — the high-Z layer goes second, never first.^{10, 11, 12}

Shielding I-125: thin lead works

I-125's photons are so low in energy that lead is extraordinarily effective. The half-value layer (HVL) follows from the mass attenuation coefficient:

For lead at 30 keV, the mass attenuation coefficient is about $\mu /\rho =30.3\mathrm{c}{\mathrm{m}}^2/g$,³ and with lead density $\rho =11.35g/c{\mathrm{m}}^3$ the linear attenuation coefficient is $\mu =344\mathrm{c}{\mathrm{m}}^{-1}$, giving:

A half-value layer of two hundredths of a millimeter means a standard 0.25 mm lead sheet is more than ten HVLs and knocks the I-125 photon field down by a factor of several thousand. Thin lead, lead foil, or leaded acrylic shields and vial shields are all highly effective for I-125. The external photon is simply not the problem — which is exactly why attention must shift to containment and intake.

A side-by-side comparison

Clinical Impact

P-32 at the bench: hands, eyes, and surveys

Because P-32's hazard is external beta dose at close range, the controls are physical and behavioral. Work behind a 10 mm acrylic bench shield; use acrylic vial and tube holders and remote-handling tongs to keep fingers away from unshielded sources; and wear an extremity (ring) dosimeter positioned to capture the highest hand dose, because the shallow-dose and extremity limits are the ones most likely to be approached when manipulating millicurie quantities. Clear embedding resin and simple acrylic constructions have been standard P-32 lab shielding for decades precisely because they stop the betas without the bremsstrahlung penalty of lead.⁹ Contamination control matters too: P-32 is a reactive, mobile contaminant, and because it is a beta emitter a standard thin-window Geiger-Müller survey (not a gamma scintillator) is the right tool to find it. Survey the work area, hands, and equipment after every use. See extremity dosimetry in nuclear medicine and contamination monitoring for the practical methods.

I-125 and the thyroid: bioassay is the program

For I-125, the external dose is a minor concern and the thyroid intake is the whole game. The control strategy is containment first: handle volatile radioiodine forms in a fume hood or glovebox, use secondary containment, and survey for both contamination and airborne activity. The detection layer is thyroid bioassay — a calibrated detector placed over the worker's thyroid to screen for any uptake after handling unsealed material.^{8, 13, 14} NRC Regulatory Guide 8.20 recommends routine thyroid bioassay when individuals handle unsealed radioiodine above activity levels that depend on the degree of containment — the open-bench threshold is the most conservative, the fume-hood threshold higher, and the glovebox threshold higher still, reflecting how much the engineering controls reduce the chance of intake. The measurement is quick, done within about 24 hours of the handling, and documented as part of the internal-dosimetry record.

Matching the hazard to the control

The deeper lesson is the one that generalizes to every unsealed radionuclide. P-32 and I-125 look superficially similar — small vials of liquid, used on a bench, labeling biomolecules — but their physics puts the hazard in completely different places, and so the programs diverge: shielding and extremity dosimetry for one, containment and thyroid bioassay for the other. A radiation safety program that starts from "what does this isotope actually emit, and where does the dose go" will arrive at the right controls; one that applies a single template to every isotope will protect against the wrong thing.

Practical Tips

• Shield P-32 with acrylic, never lead. Use about 10 mm of acrylic as the primary beta shield; reserve any high-Z material for a secondary bremsstrahlung layer behind the acrylic, and only at high activity.
• Use a beta-sensitive survey instrument for P-32. A thin-window Geiger-Müller probe detects P-32 contamination; a sodium-iodide gamma probe will miss it.
• Wear and position extremity dosimetry. For hands-on P-32 work, a ring badge placed to capture the highest finger dose is the monitor that matters most, because the extremity limit is 50 rem (0.5 Sv) per year.
• Contain volatile I-125. Handle radioiodine in a fume hood or glovebox, use secondary containment, and keep the activity consistent with your containment level.
• Run thyroid bioassay for I-125 handlers. Screen the thyroid after handling unsealed radioiodine above the Regulatory Guide 8.20 action levels, and document the result.
• Post, label, and survey. Post areas and label containers per 10 CFR 20.1902 and 20.1904, keep survey and bioassay records per 10 CFR 20.2103, and set monitoring based on the 10% trigger in 10 CFR 20.1502.
• Decay-in-storage short-lived waste. P-32 (14 d) and even I-125 (59 d) are good candidates for decay-in-storage; hold, survey to background, then dispose per your license.

Regulatory Considerations

Research use of unsealed P-32 and I-125 is licensed under 10 CFR Part 30 — not Part 35 — and must meet the radiation-protection standards of 10 CFR Part 20. This distinction matters. 10 CFR Part 35 governs the medical use of byproduct material administered to humans; bench research that labels molecules and never doses a patient is licensed under 10 CFR Part 30, with large multi-isotope research programs operating under a broad-scope license under 10 CFR Part 33. Using the medical-use rule as your framework for a research lab is a category error.

The core radiation-protection requirements come from 10 CFR Part 20:

• 10 CFR 20.1201 sets the occupational dose limits: 5 rem (0.05 Sv) annual total effective dose equivalent, 15 rem (0.15 Sv) to the lens of the eye, and 50 rem (0.5 Sv) shallow-dose equivalent to the skin of the whole body or to any extremity.⁴ The extremity limit is the one most relevant to hands-on P-32 work.
• 10 CFR 20.1502 requires individual monitoring when a worker is likely to receive more than 10% of those limits, or an intake exceeding 10% of the annual limit on intake — the trigger for issuing dosimeters and for a bioassay program.⁵
• 10 CFR 20.1902 and 20.1904 require posting of radiation areas and labeling of containers of radioactive material.
• 10 CFR 20.2103 requires that surveys and measurements used to demonstrate compliance and to determine dose be recorded and retained.

For radioiodine intake, NRC Regulatory Guide 8.20, Revision 2, "Applications of Bioassay for Radioiodine," provides the recommended thyroid-bioassay program, including the containment-dependent activity levels that trigger routine bioassay.⁸ Of the states DRPS serves, Florida, Maryland, Virginia, California, Nevada, Pennsylvania, New York, and New Jersey are NRC Agreement States that administer equivalent programs, while Washington, DC and Delaware are regulated directly by the NRC for radioactive material. A facility should confirm which authority issues its license and whose rules apply. DRPS supports research and medical facilities with radiation safety officer services, radioactive material license support, and radiation safety training.

Frequently Asked Questions (FAQs)

Why do you shield P-32 with acrylic instead of lead?

P-32 is a high-energy pure beta emitter. When its fast beta particles are stopped by a high-atomic-number material like lead, a larger fraction of their energy is converted into penetrating bremsstrahlung x-rays. A low-atomic-number material such as acrylic (Plexiglas) stops the betas while producing far less bremsstrahlung, so about a centimeter of acrylic is the correct primary shield. Lead as a primary P-32 shield is counterproductive.

How thick does the acrylic need to be for P-32?

The maximum range of P-32 beta particles is roughly 8 mm in tissue or water and about 6 to 7 mm in acrylic. Because the continuous-slowing-down range underestimates the deepest-penetrating betas, standard practice is to round up to about 10 mm (three-eighths inch) of acrylic to stop essentially all of the betas with margin.

What is the main hazard of I-125?

I-125 emits only low-energy photons of about 27 to 35 keV, so external shielding is easy — a few tenths of a millimeter of lead stops it. The dominant hazard is internal: if unsealed I-125 is inhaled or ingested, iodine concentrates in the thyroid, so workers who handle significant quantities need thyroid bioassay (direct thyroid counting) to detect any intake.

How much lead stops I-125?

Because I-125 photons are only 27 to 35 keV, the half-value layer in lead is roughly 0.02 to 0.03 mm. A standard quarter-millimeter (0.25 mm) lead sheet is many half-value layers and attenuates the I-125 photon field by a factor of thousands, so thin lead or leaded acrylic is highly effective.

What dose limits apply to lab workers using these isotopes?

Under 10 CFR 20.1201, the annual occupational limits are 5 rem (0.05 Sv) total effective dose equivalent, 15 rem (0.15 Sv) to the lens of the eye, and 50 rem (0.5 Sv) shallow-dose equivalent to the skin or to any extremity. Because beta dose to the hands can be significant when handling P-32, extremity (ring) monitoring is commonly required.

Which NRC rules govern research use of P-32 and I-125?

Bench research with unsealed byproduct material is licensed under 10 CFR Part 30 (with broad-scope research programs under 10 CFR Part 33) and must meet the radiation-protection standards of 10 CFR Part 20. 10 CFR Part 35, the medical-use rule, applies only when byproduct material is administered to humans, so it is not the governing part for laboratory research.

Does a worker handling P-32 need bioassay?

P-32 bioassay is situation-dependent and less standardized than for radioiodine; routine bioassay is driven by the activity handled and the potential for intake. For I-125 and other radioiodines, NRC Regulatory Guide 8.20 recommends routine thyroid bioassay when workers handle unsealed radioiodine above activity levels that depend on whether the work is done on an open bench, in a fume hood, or in a glovebox.

Key Takeaways

• P-32 and I-125 have opposite hazard profiles. One is a hard external beta emitter; the other is a soft-photon emitter whose real danger is internal thyroid uptake.
• Shield P-32 with low-Z acrylic, not lead. Lead maximizes bremsstrahlung; about 10 mm of acrylic stops the betas with minimal x-ray production.
• I-125 external dose is trivial to shield. A quarter-millimeter of lead is many half-value layers; the program must focus on containment and thyroid bioassay.
• Monitor the right quantity. Extremity (ring) dosimetry and beta-sensitive surveys for P-32; thyroid bioassay and airborne/contamination surveys for I-125.
• Know your license basis. Research use is 10 CFR Part 30 (broad scope Part 33) under Part 20 — not the Part 35 medical-use rule.
• Match the control to the physics. The general method is to ask what the isotope emits and where the dose goes, then build the program around that answer.

Conclusion

P-32 and I-125 are a two-isotope course in radiation safety. One teaches that shielding is about more than thickness — that stopping a hard beta in the wrong material trades a short-range hazard for a penetrating one, and that the right answer is low-Z acrylic. The other teaches that external dose is sometimes the least of your worries, and that an isotope you can shield with foil can still deliver a committed thyroid dose if it gets inside you. Between them they cover the whole logic of unsealed-source safety: identify the emission, follow the dose, and choose controls that fit.

A research radiation safety program that internalizes this — acrylic and ring badges for the beta emitter, containment and bioassay for the iodine, the correct license basis for both — protects its workers with modest, well-understood measures. The isotopes are forgiving when you respect their physics and unforgiving when you do not.

How DRPS Can Help

Diagnostic Radiation Physics Services helps research institutions and medical facilities build radiation safety programs for unsealed radionuclides that are matched to the actual physics of each isotope. This includes shielding design and verification, extremity and whole-body dosimetry program setup, thyroid bioassay program design for radioiodine, contamination-survey and instrument-selection guidance, license support under 10 CFR Part 30 and Part 33, and worker training. Our work spans radiation safety officer services, radioactive material license support, and radiation safety training.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware.

Good radiation safety is not about applying more controls. It is about applying the right controls for the radiation you actually have.

Related Resources

• Beta and bremsstrahlung shielding for beta emitters
• C-14 and tritium low-energy beta radiation safety
• Thyroid bioassay for I-131 workers
• NRC occupational dose limits (Part 20)
• Contamination monitoring and frisking
• Extremity dosimetry in nuclear medicine
• Radiation Safety Officer consulting
• Radioactive material license support

References

1. National Nuclear Data Center, Brookhaven National Laboratory. NuDat 3 / ENSDF decay data for P-32 and I-125. nndc.bnl.gov
2. National Institute of Standards and Technology. ESTAR: Stopping Powers and Ranges for Electrons. nist.gov
3. National Institute of Standards and Technology. X-Ray Mass Attenuation Coefficients — Lead (Z = 82). nist.gov
4. U.S. Nuclear Regulatory Commission. 10 CFR 20.1201: Occupational Dose Limits for Adults. ecfr.gov
5. U.S. Nuclear Regulatory Commission. 10 CFR 20.1502: Conditions Requiring Individual Monitoring of External and Internal Occupational Dose. ecfr.gov
6. U.S. Nuclear Regulatory Commission. 10 CFR Part 30: Rules of General Applicability to Domestic Licensing of Byproduct Material. ecfr.gov
7. U.S. Nuclear Regulatory Commission. 10 CFR Part 33: Specific Domestic Licenses of Broad Scope for Byproduct Material. ecfr.gov
8. U.S. Nuclear Regulatory Commission. Regulatory Guide 8.20, Revision 2: Applications of Bioassay for Radioiodine. Washington, DC: NRC; 2011. nrc.gov
9. Merrifield RK. The construction of radiation shielding for use with phosphorus-32 labeling in molecular biology. Anal Biochem. 1987;167(2):400-405. doi:10.1016/0003-2697(87)90183-7. PubMed
10. Tijani SA, Al-Hadeethi Y, Sambo I, Balogun FA. Shielding of beta and bremsstrahlung radiation with transparent glasses in therapeutic nuclear medicine. J Radiol Prot. 2018;38(3):N44-N51. doi:10.1088/1361-6498/aad2be. PubMed
11. Mrdja D, Bikit K, Bikit I, Slivka J, Forkapic S, Knezevic J. Monte Carlo simulation of beta particle-induced bremsstrahlung doses. J Radiol Prot. 2017;38(1):34-47. doi:10.1088/1361-6498/aa928f. PubMed
12. Murata T, Miwa K, Matsubayashi F, et al. Optimal radiation shielding for beta and bremsstrahlung radiation emitted by Sr-89 and Y-90: validation by empirical approach and Monte Carlo simulations. Ann Nucl Med. 2014;28(7):617-622. doi:10.1007/s12149-014-0853-6. PubMed
13. Baechler S, Stritt N, Bochud FO. Individual monitoring of internal exposure for nuclear medicine workers in Switzerland. Radiat Prot Dosimetry. 2010;144(1-4):464-467. doi:10.1093/rpd/ncq350. PubMed
14. Meisenberg O, Gerstmann UC. Thyroid monitoring of adults and children after reactor accidents with a new dose rate measurement device. Appl Radiat Isot. 2017;125:150-153. doi:10.1016/j.apradiso.2017.04.006. PubMed